Association of resistin polymorphisms with resistin levels and lipid profile in children

[1]  C. Garcés,et al.  Resistin levels are related to fat mass, but not to body mass index in children , 2013, Peptides.

[2]  A. Karaoğlu,et al.  Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children. , 2013, Biomarkers in medicine.

[3]  M. Andersen,et al.  Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study , 2013, Molecular Biology Reports.

[4]  F. Mach,et al.  Serum resistin and inflammatory and endothelial activation markers in obese adolescents. , 2012, The Journal of pediatrics.

[5]  A. Ben Abdelaziz,et al.  Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. , 2012, Genetic testing and molecular biomarkers.

[6]  S. Oros,et al.  Adipocytokine profile and insulin resistance in childhood obesity. , 2012, Maedica.

[7]  C. Bal,et al.  Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. , 2009, Experimental and therapeutic medicine.

[8]  Hyo‐Soo Kim,et al.  Human resistin in cardiovascular disease. , 2012, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[9]  J. Harrell,et al.  Relationship between Cardiovascular Risk Factors and Adipokines in Adolescents , 2011, Hormone Research in Paediatrics.

[10]  Cia-Hin Lau,et al.  Adiponectin and Resistin Gene Polymorphisms in Association with Their Respective Adipokine Levels , 2011, Annals of human genetics.

[11]  T. Reinehr,et al.  Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. , 2011, Metabolism: clinical and experimental.

[12]  S. Rashid,et al.  Human Resistin Stimulates Hepatic Overproduction of Atherogenic ApoB-Containing Lipoprotein Particles by Enhancing ApoB Stability and Impairing Intracellular Insulin Signaling , 2011, Circulation research.

[13]  A. Syrenicz,et al.  Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. , 2011, Endokrynologia Polska.

[14]  M. Szydłowski,et al.  Polymorphisms in 5′-flanking regions of genes encoding adiponectin, leptin, and resistin are not associated with obesity of Polish children and adolescents , 2011, Molecular Biology Reports.

[15]  D. Pupek-Musialik,et al.  Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans. , 2010, Neuro endocrinology letters.

[16]  H. Izawa,et al.  Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population , 2010, Diabetologia.

[17]  G. Groothuis,et al.  Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  D. D. de Luis,et al.  Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. , 2009, Diabetes research and clinical practice.

[19]  C. Fox,et al.  Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study , 2009, Diabetes.

[20]  Y. Kesäniemi,et al.  Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors , 2008, Regulatory Peptides.

[21]  A. Lezcano,et al.  Estudio transversal español de crecimiento 2008. Parte II: valores de talla, peso e índice de masa corporal desde el nacimiento a la talla adulta , 2008 .

[22]  I. Zineh,et al.  Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. , 2008, Metabolism: clinical and experimental.

[23]  W. Hul,et al.  Analysis of Genetic Variations in the Resistin Gene Shows No Associations With Obesity in Women , 2008, Obesity.

[24]  J. López-Siguero,et al.  [Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood]. , 2008, Anales de pediatria.

[25]  G. Norata,et al.  Plasma resistin levels correlate with determinants of the metabolic syndrome. , 2007, European journal of endocrinology.

[26]  Liansheng Wang,et al.  A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. , 2007, Clinical chemistry and laboratory medicine.

[27]  A. Doria,et al.  Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. , 2006, The Journal of clinical endocrinology and metabolism.

[28]  T. Yoshikawa,et al.  Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity , 2005, Acta Diabetologica.

[29]  Y. Kesäniemi,et al.  Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[30]  Chia-Ing Li,et al.  Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. , 2005, Metabolism: clinical and experimental.

[31]  R. N. Bergman,et al.  Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects , 2004, Diabetologia.

[32]  T. Saruta,et al.  Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[33]  M. Hutz,et al.  A resistin gene polymorphism is associated with body mass index in women , 2004, Human Genetics.

[34]  M. Lazar,et al.  The current biology of resistin , 2004, Journal of internal medicine.

[35]  H. K. Lee,et al.  Erratum to: Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans , 2004, Diabetologia.

[36]  Y. M. Cho,et al.  Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans , 2004, Diabetologia.

[37]  Steven R Smith,et al.  A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. , 2003, Diabetes.

[38]  E. Ros,et al.  Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. , 2003, Metabolism: clinical and experimental.

[39]  Scott M. Williams,et al.  5' flanking variants of resistin are associated with obesity. , 2002, Diabetes.

[40]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.